Evolent Health, Inc. Announces Third Quarter 2026 Financial Results

Evolent Health announced its third-quarter 2026 financial results, but the article does not provide revenue, profit, or growth figures. The company renewed its largest Surgical Management customer contract for four years; the customer was acquired through Evolent’s 2022 purchase of IPG. CEO Seth Blackley cited strong execution on 2026 oncology launches and demand for AI-powered specialty care, as the company focuses on growth and margin expansion through its clinical and administrative technology platform.